Rize Oncology Inc. (RZONF)
Market Closed
10 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
32.3K Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 0
Previous Close Want to track RZONF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rize Oncology Inc. (RZONF) Statistics
Valuation metrics
Market Cap 32.3K
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.07
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 75.74M
Float -
Shares short -
% Held by insiders 0.77%
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0
52-Week high 0
Beta -
50-Day moving average 0
200-Day moving average 0
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.46%
Return on equity -0.5%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -550.92K
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 14.35%
Book value per share (mrq) 0.01
Cash Flow
Cash flow statement -524.8K
Levered free cash flow (LFCF) -550.92K
